Search for: "Field Developers, Inc. v. Johnson"
Results 61 - 80
of 114
Sorted by Relevance
|
Sort by Date
27 Mar 2018, 4:09 pm
Siracusano (2011) and Omnicare, Inc. v. [read post]
13 Dec 2023, 8:49 am
Robert Wood Johnson University Hosp., Inc., 634 F.Supp.2d 1226, 1246 (D. [read post]
3 Feb 2012, 12:56 pm
Johnson, 302 F.3d 139 (3d Cir. 2002). [read post]
15 Sep 2011, 4:06 am
Johnson & Johnson L.P., 2009 WL 2252198, at *2-3 (D. [read post]
2 Mar 2018, 11:26 am
Jansen Pharmaceuticals, part of Johnson & Johnson, devloped the drug and manufactures it. [read post]
4 Jun 2019, 9:30 pm
’ Jon Connolly, Tom Johnson, Lena Salaymeh, reminded us of normativity of legal field, that makes interdisciplinary research in law and legalities methodologically challenging and still not conventionally ‘legitimate’ in practice. [read post]
2 Sep 2021, 2:00 am
Knox Trailers, Inc. v. [read post]
28 Apr 2008, 11:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC vacates FTC’s decision that Rambus breached antitrust duty by violating JEDEC patent disclosure rules and orders new trial: (Philip Brooks), (Techdirt), (Ars Technica), (IP Law360), (Peter Zura's 271 Patent Blog), (Hal Wegner), (IPBiz), (IP Law360), UK Court of Appeal rules on whether prior art not in the same design… [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram)… [read post]
12 Jan 2022, 12:35 pm
The cases are Students for Fair Admissions, Inc. v. [read post]
15 Dec 2010, 2:43 pm
Johnson and Steven P. [read post]
14 Jul 2016, 7:16 am
From a panel decision Bennie v. [read post]
31 Oct 2007, 8:23 am
J. 20 *** Susan Power Johnston, CRAM-DOWN INTEREST RATES: DEVELOPMENTS FOLLOWING TILL V. [read post]
18 Jun 2012, 4:17 am
In Riegel v. [read post]
11 Jan 2011, 1:21 pm
Johnson, 706 S.W.2d 815, 817-18 (Mo.banc 1985) (bias); State v. [read post]
30 Apr 2012, 11:19 am
(Sierra Club, Inc. v. [read post]
28 Jan 2023, 7:32 am
In response to the rapid growth of market practices with respect to ESG investing to assess and manage climate transition risks in financial markets, the OECD Committee on Financial Markets (CMF) has developed a substantive body of work that provides analysis on challenges with respect to current market practices, and proposes policy considerations to improve them (OECD, Policy guidance on market practices to strengthen ESG investing and finance a climate transition. p. 7)ESG initiatives… [read post]
20 Dec 2015, 4:47 am
For that point, the brief sites Seymour v. [read post]
6 May 2010, 4:12 pm
Metabolife International, Inc., 401 F.3d 1233, 1247 (11th Cir. 2005); Goebel v. [read post]
21 Feb 2023, 6:41 am
Gravel v. [read post]
